Literature DB >> 26276391

Prolyl isomerase Pin1 negatively regulates AMP-activated protein kinase (AMPK) by associating with the CBS domain in the γ subunit.

Yusuke Nakatsu1, Misaki Iwashita2, Hideyuki Sakoda3, Hiraku Ono4, Kengo Nagata1, Yasuka Matsunaga1, Toshiaki Fukushima1, Midori Fujishiro3, Akifumi Kushiyama5, Hideaki Kamata1, Shin-Ichiro Takahashi6, Hideki Katagiri7, Hiroaki Honda8, Hiroshi Kiyonari9, Takafumi Uchida10, Tomoichiro Asano11.   

Abstract

AMP-activated protein kinase (AMPK) plays a critical role in metabolic regulation. In this study, first, it was revealed that Pin1 associates with any isoform of γ, but not with either the α or the β subunit, of AMPK. The association between Pin1 and the AMPK γ1 subunit is mediated by the WW domain of Pin1 and the Thr(211)-Pro-containing motif located in the CBS domain of the γ1 subunit. Importantly, overexpression of Pin1 suppressed AMPK phosphorylation in response to either 2-deoxyglucose or biguanide stimulation, whereas Pin1 knockdown by siRNAs or treatment with Pin1 inhibitors enhanced it. The experiments using recombinant Pin1, AMPK, LKB1, and PP2C proteins revealed that the protective effect of AMP against PP2C-induced AMPKα subunit dephosphorylation was markedly suppressed by the addition of Pin1. In good agreement with the in vitro data, the level of AMPK phosphorylation as well as the expressions of mitochondria-related genes, such as PGC-1α, which are known to be positively regulated by AMPK, were markedly higher with reduced triglyceride accumulation in the muscles of Pin1 KO mice as compared with controls. These findings suggest that Pin1 plays an important role in the pathogenic mechanisms underlying impaired glucose and lipid metabolism, functioning as a negative regulator of AMPK.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  AMP-activated kinase (AMPK); diabetes; energy metabolism; lipid metabolism; metabolic syndrome; muscle; prolyl isomerase

Mesh:

Substances:

Year:  2015        PMID: 26276391      PMCID: PMC4591812          DOI: 10.1074/jbc.M115.658559

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  51 in total

Review 1.  The AMP-activated protein kinase--fuel gauge of the mammalian cell?

Authors:  D G Hardie; D Carling
Journal:  Eur J Biochem       Date:  1997-06-01

2.  A novel ES cell line, TT2, with high germline-differentiating potency.

Authors:  T Yagi; T Tokunaga; Y Furuta; S Nada; M Yoshida; T Tsukada; Y Saga; N Takeda; Y Ikawa; S Aizawa
Journal:  Anal Biochem       Date:  1993-10       Impact factor: 3.365

Review 3.  The AMP-activated protein kinase pathway--new players upstream and downstream.

Authors:  D Grahame Hardie
Journal:  J Cell Sci       Date:  2004-11-01       Impact factor: 5.285

Review 4.  The AMP-activated protein kinase cascade--a unifying system for energy control.

Authors:  David Carling
Journal:  Trends Biochem Sci       Date:  2004-01       Impact factor: 13.807

5.  Regulation of the TSC pathway by LKB1: evidence of a molecular link between tuberous sclerosis complex and Peutz-Jeghers syndrome.

Authors:  Michael N Corradetti; Ken Inoki; Nabeel Bardeesy; Ronald A DePinho; Kun-Liang Guan
Journal:  Genes Dev       Date:  2004-07-01       Impact factor: 11.361

6.  5'-AMP inhibits dephosphorylation, as well as promoting phosphorylation, of the AMP-activated protein kinase. Studies using bacterially expressed human protein phosphatase-2C alpha and native bovine protein phosphatase-2AC.

Authors:  S P Davies; N R Helps; P T Cohen; D G Hardie
Journal:  FEBS Lett       Date:  1995-12-27       Impact factor: 4.124

7.  A human peptidyl-prolyl isomerase essential for regulation of mitosis.

Authors:  K P Lu; S D Hanes; T Hunter
Journal:  Nature       Date:  1996-04-11       Impact factor: 49.962

8.  Intrasteric control of AMPK via the gamma1 subunit AMP allosteric regulatory site.

Authors:  Julian Adams; Zhi-Ping Chen; Bryce J W Van Denderen; Craig J Morton; Michael W Parker; Lee A Witters; David Stapleton; Bruce E Kemp
Journal:  Protein Sci       Date:  2004-01       Impact factor: 6.725

9.  The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress.

Authors:  Reuben J Shaw; Monica Kosmatka; Nabeel Bardeesy; Rebecca L Hurley; Lee A Witters; Ronald A DePinho; Lewis C Cantley
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-25       Impact factor: 11.205

10.  AMP-activated protein kinase plays a role in the control of food intake.

Authors:  Ulrika Andersson; Karin Filipsson; Caroline R Abbott; Angela Woods; Kirsty Smith; Stephen R Bloom; David Carling; Caroline J Small
Journal:  J Biol Chem       Date:  2004-01-23       Impact factor: 5.157

View more
  12 in total

1.  Circulating levels of PIN1 and glucose metabolism in young people with obesity.

Authors:  M Bianchi; M Manco
Journal:  J Endocrinol Invest       Date:  2022-05-18       Impact factor: 5.467

2.  The prolyl isomerase Pin1 increases β-cell proliferation and enhances insulin secretion.

Authors:  Yusuke Nakatsu; Keiichi Mori; Yasuka Matsunaga; Takeshi Yamamotoya; Koji Ueda; Yuki Inoue; Keiko Mitsuzaki-Miyoshi; Hideyuki Sakoda; Midori Fujishiro; Suguru Yamaguchi; Akifumi Kushiyama; Hiraku Ono; Hisamitsu Ishihara; Tomoichiro Asano
Journal:  J Biol Chem       Date:  2017-05-31       Impact factor: 5.157

3.  Brown Algae Polyphenol, a Prolyl Isomerase Pin1 Inhibitor, Prevents Obesity by Inhibiting the Differentiation of Stem Cells into Adipocytes.

Authors:  Atsuko Suzuki; Toshiyuki Saeki; Hiroko Ikuji; Chiyoko Uchida; Takafumi Uchida
Journal:  PLoS One       Date:  2016-12-30       Impact factor: 3.240

Review 4.  Pin1 Modulation in Physiological Status and Neurodegeneration. Any Contribution to the Pathogenesis of Type 3 Diabetes?

Authors:  Marzia Bianchi; Melania Manco
Journal:  Int J Mol Sci       Date:  2018-08-08       Impact factor: 5.923

5.  Possible involvement of normalized Pin1 expression level and AMPK activation in the molecular mechanisms underlying renal protective effects of SGLT2 inhibitors in mice.

Authors:  Masa-Ki Inoue; Yasuka Matsunaga; Yusuke Nakatsu; Takeshi Yamamotoya; Koji Ueda; Akifumi Kushiyama; Hideyuki Sakoda; Midori Fujishiro; Hiraku Ono; Misaki Iwashita; Tomomi Sano; Fusanori Nishimura; Kenichi Morii; Kensuke Sasaki; Takao Masaki; Tomoichiro Asano
Journal:  Diabetol Metab Syndr       Date:  2019-07-22       Impact factor: 3.320

6.  Liraglutide Treatment Ameliorates Neurotoxicity Induced by Stable Silencing of Pin1.

Authors:  Marzia Bianchi; Valentina D'Oria; Maria Rita Braghini; Stefania Petrini; Melania Manco
Journal:  Int J Mol Sci       Date:  2019-10-12       Impact factor: 5.923

7.  Pathological Role of Pin1 in the Development of DSS-Induced Colitis.

Authors:  Yasuka Matsunaga; Shun Hasei; Takeshi Yamamotoya; Hiroaki Honda; Akifumi Kushiyama; Hideyuki Sakoda; Midori Fujishiro; Hiraku Ono; Hisanaka Ito; Takayoshi Okabe; Tomoichiro Asano; Yusuke Nakatsu
Journal:  Cells       Date:  2021-05-17       Impact factor: 6.600

Review 8.  Physiological and Pathogenic Roles of Prolyl Isomerase Pin1 in Metabolic Regulations via Multiple Signal Transduction Pathway Modulations.

Authors:  Yusuke Nakatsu; Yasuka Matsunaga; Takeshi Yamamotoya; Koji Ueda; Yuki Inoue; Keiichi Mori; Hideyuki Sakoda; Midori Fujishiro; Hiraku Ono; Akifumi Kushiyama; Tomoichiro Asano
Journal:  Int J Mol Sci       Date:  2016-09-07       Impact factor: 5.923

9.  Trk-fused gene (TFG) regulates pancreatic β cell mass and insulin secretory activity.

Authors:  Takeshi Yamamotoya; Yusuke Nakatsu; Akifumi Kushiyama; Yasuka Matsunaga; Koji Ueda; Yuki Inoue; Masa-Ki Inoue; Hideyuki Sakoda; Midori Fujishiro; Hiraku Ono; Hiroshi Kiyonari; Hisamitsu Ishihara; Tomoichiro Asano
Journal:  Sci Rep       Date:  2017-10-12       Impact factor: 4.379

Review 10.  Pin1 Plays Essential Roles in NASH Development by Modulating Multiple Target Proteins.

Authors:  Masa-Ki Inoue; Yusuke Nakatsu; Takeshi Yamamotoya; Shun Hasei; Mayu Kanamoto; Miki Naitou; Yasuka Matsunaga; Hideyuki Sakoda; Midori Fujishiro; Hiraku Ono; Akifumi Kushiyama; Tomoichiro Asano
Journal:  Cells       Date:  2019-11-29       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.